FindLaw | Find a Lawyer. Find Answers.

Library Search

• IP Strategies In Deals. Seminar Summary of Speaker Glynna K. Christian of Thelen Reid and Priest LLP. ( June 2004 )
  

  Glynna K. Christian, a partner at Thelen Reid and Priest, discussed the various ways to structure IP rights in complex multi-jurisdiction and multiparty deals.

• IP Strategies In Deals. Seminar Summary of Speaker Jorge Contreras of Hale and Dorr LLP ( June 2004 )
  

  Jorge Contreras, partner at Hale and Dorr LLP, discussed how to select the best structure for deals in IP joint ventures. He observed that in his experience, clients use contractual relationships versus formal joint ventures with equal frequency.

• Technology-Based Joint Ventures ( February 2004 )
  

  Technology-based joint ventures are subject to rapidly changing technical standards, fluctuating markets and an emphasis on intangible services. But with careful legal planning, the joint venture can be an extremely effective vehicle for bringing together technology companies wishing to tap each other’s intellectual property assets, often allowing these parties to reach new markets or expand existing relationships.

• The Post Sarbanes-Oxley World ( December 2003 )
  

  Jordan Eth, a Partner at Morrison Foerster, presented a discussion on securities enforcement and litigation, and focused particular attention on the top pitfalls for corporate clients in the area of Sarbanes-Oxley compliance that deals with requests for documents from the SEC.

• Is Your Life Sciences Company Ready for Financing? ( March 2003 )
  

  For venture capitalists, Life Science companies have become all the rage. In 2002, even amidst the continual economic downturn, investments in the Life Science industry grew significantly as a percentage of total venture capital investments. Last year, the Life Sciences sector was notably one of the few fund-raising bright spots. This bulletin examines the strength of the Life Science industry relative to the current climate of venture capital investing and provides an overview of basic issues for a Life Science company to consider <i>before</i> seeking venture financing.

• WTO & Its Impact On China's Retail and Franchise Industries ( November 2001 )
  

  Prior to China's entry into WTO, foreign investments were severely restricted from providing retail services in China for both their own proprietary operations and for third parties. The PRC retail sector was first opened to foreign investment with the promulgation of the <i>Official Reply to Utilizing Foreign Investment in Commercial Retail</i> issued by the State Council in July, 1992.

• Venture Finance in the (New) New Economy ( September 2000 )
  

  This article reviews how companies should have a solid business plan when seeking venture capital in the new economy.

• Western Companies and China: No Longer a Slow Boat ( December 2000 )
  

  The People's Republic of China (PRC) and its people welcome American business ventures, but without the knowledge and expertise of an experienced legal team, companies seeking to do business in China can place themselves at risk.

• Antitrust Considerations In Establishing Medical Provider Networks ( December 1999 )
  

  This article outlines the procedures a medical provider should follow in forming networks, and safeguards that should be observed to minimize anti-trust risk.